These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12412346)

  • 1. [Tumor markers and ovarian cancer].
    Trifonov I; Todorova M
    Akush Ginekol (Sofiia); 2002; 41 Suppl 1():7-11. PubMed ID: 12412346
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers for ovarian cancers].
    Aoki D; Kataoka F; Susumu N; Nozawa S
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
    [No Abstract]   [Full Text] [Related]  

  • 3. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
    Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
    Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
    Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
    Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
    Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of tumour markers in ovarian cancer.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
    [No Abstract]   [Full Text] [Related]  

  • 8. [CA 125 in epithelial ovarian cancer].
    Mogensen O
    Ugeskr Laeger; 1998 May; 160(22):3236. PubMed ID: 9621807
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biomarker in gynecologic malignancies].
    Isonishi S
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1003-7. PubMed ID: 15272576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of tumor marker determinations in the primary therapy of ovarian cancer.
    Meier W; Baumgartner L; Stieber P; Hasholzner U; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2949-51. PubMed ID: 9329572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological markers of ovarian cancer].
    Dobryszycka W
    Postepy Hig Med Dosw; 1986; 40(6):668-713. PubMed ID: 2440015
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the test methods (KRYPTOR, ES 600 and CIS-RIA) for CEA, CA 15-3 and CA 125 follow-up and ONCOCHECK-quality control.
    Bauer T; Charl S; Sturm G
    Anticancer Res; 2000; 20(6D):5245-7. PubMed ID: 11326703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 14. [CA-125 antigen].
    Zakrzewska I
    Postepy Hig Med Dosw; 2002; 56(1):29-38. PubMed ID: 11987487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor markers and ovarian cysts].
    Vinatier D; Houfflin V; Collinet P
    J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(1 Suppl):S34-40. PubMed ID: 11917374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality control in tumor marker values: methology, results and potential problems].
    Ben Ayed M; Ben Hadj Hmida Y; Kassis M; Damak J; Masmoudi H
    Tunis Med; 2001; 79(6-7):341-7. PubMed ID: 11771428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumour markers in epithelial ovarian cancer].
    Sparholt MH; Høgdall E; Høgdall CK
    Ugeskr Laeger; 2009 Nov; 171(48):3505-9. PubMed ID: 19944049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The present status of tumor markers in malignant ovarian tumor].
    Nishimura H; Miyoshi T; Hamai J; Miyahara K
    Gan No Rinsho; 1985 May; 31(6 Suppl):589-93. PubMed ID: 2411960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early proteomics in ovarian cancer: myth or reality?].
    Makarov OV; Govorun VM; Taranets IN; Goufman EI; Gritsaĭ AN; Archakov AI
    Biomed Khim; 2003; 49(1):2-7. PubMed ID: 14569865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.